CROSSLINK
"CROSSLINK" is a word mark owned by Crosslink Therapeutics Inc., filed at the USPTO on March 2, 2025. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since August 11, 2026
- Filed
- March 2, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99063357
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns CROSSLINK
The owner and representative on file with the office.
Owner
Crosslink Therapeutics Inc.
Boston, United States
Representative
Michael Graif
Brown Rudnick LLP
What the mark covers
The products and services CROSSLINK is filed for, grouped by Nice class.
Biological preparations for the treatment of cancer, namely protein-based therapeutics that reversibly assemble on the surface of cancer cells
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Notice of revival - e-mailed
- Petition to revive-granted
10 earlier steps on the official record.
About CROSSLINK
Who owns the trademark "CROSSLINK"?
The USPTO trademark "CROSSLINK" (application 99063357) is owned by Crosslink Therapeutics Inc.
What is the status of "CROSSLINK"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull CROSSLINK and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a80-f22d-76a2-ba11-e64e2eaf6233
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a80-f22d-76a2-ba11-e64e2eaf6233",
"object": "trademark",
"mark_text": "CROSSLINK",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99063357",
"filing_date": "2025-03-02",
"nice_classes": [
5
],
"owners": [
{
"name": "Crosslink Therapeutics Inc.",
"entity_id": null
}
]
}